Visualitza Articles (Hospital del Mar Research Institute) per matèria "Echinocandins"

Ara mostrant els elements 1-2 de 2

Candida periprosthetic joint infection: A rare and difficult-to-treat infection

Escolà-Vergé, Laura; Sorli Redó, M. Luisa; Pigrau, C.; Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC); Spanish Network for Research in Infectious Pathology (REIPI) (Elsevier, 2018)

BACKGROUND: Candida periprosthetic joint infection (CPJI) is a rare, difficult-to-treat disease. The purpose of this study was to evaluate the clinical characteristics and outcomes of CPJI treated with various surgical and ...
Rezafungin versus Caspofungin in a phase 2, randomized, double-blind study for the treatment of candidemia and invasive candidiasis - the STRIVE trial

Thompson, George R.; Soriano, Alex; Skoutelis, Athanasios; Vazquez, Jose A.; Honore, Patrick M.; Horcajada Gallego, Juan Pablo; Spapen, Herbert; Bassetti, Matteo; Ostrosky-Zeichner, Luis; Das, Anita F.; Viani, Rolando M.; Sandison, Taylor; Pappas, Peter G. (Oxford University Press, 2021)

Background: Rezafungin (RZF) is a novel echinocandin exhibiting distinctive pharmacokinetics/pharmacodynamics. STRIVE was a phase 2, double-blind, randomized trial designed to compare the safety and efficacy of RZF once ...